Heshu Abdullah - Koolmees

DR.

Affiliatie VU Amsterdam institute for Immunology and Infectious diseases Physician, Pharmacy and Clinical Pharmacology

Specialization

Focus of research

Latest publications

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study
Guchelaar, H.-J., van der Wouden, C. H., Manson, L. E. N., Abdullah-Koolmees, H., Blagec, K., Blagus, T., Böhringer, S., Cecchin, E., Cheung, K.-C., Deneer, V. H. M., Jonsson, S., Joefield-Roka, C., Just, K. S., Karlsson, M. O., Konta, L., Koopmann, R., Kriek, M., Lehr, T., Mitropoulou, C. & Rollinson, V. & 13 others, Roncato, R., Samwald, M., Schaeffeler, E., Skokou, M., Schwab, M., Steinberger, D., Stingl, J. C., Tremmel, R., Turner, R. M., van Rhenen, M. H., Dávila-Fajardo, C. L., Dolžan, V. & Ubiquitous Pharmacogenomics Consortium, 2025, (E-pub ahead of print) In: Clinical Pharmacology and Therapeutics.
Research output: Contribution to journal › Article* › Academic › peer-review
Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19
Minnema, J., Lafeber, M., Sablerolles, R. S. G., van Kempen, J. A. L., Tap, L., Polinder-Bos, H. A., van de Loo, B. P. A., van der Kuy, H., Faes, M. C., Aleman, J., Tournoy, J., van der Linden, L., Gambera, M., Martignoni, I., van Etten, R., van Onzenoort, H., Kappers, M., van Wijngaarden, P., Verstijnen, J. & Theeuwes, V. & 82 others, Kemper, M., Slob, E., Sombogaard, F., Abdullah-Koolmees, H., van den Berg, R., de Wit, H., Dilek, B., Hogenhuis, F., Buyukayten, V., te Brake, B., Nieuwenhuijzen, M., Scheeren, M., de Wit, M., Bulsink, A., van Haelst, I., ter Horst, P., Moorlag, R., Vos, A., Otten-Helmers, A., van Kan, E., Voskamp, M., Ebbens, M., Ezinga, M., van Nieuwkoop, C., Visser, L., Ghazarian, C., Hilarius, D., Hermanides, G., Bresser, C., Derijks-Engwegen, J., Boemaars, E., Getrouw, Z., Maat, B., Wierenga, P., Bosch, T., Krens, L., Liang, K., Saleh, L., van Heuckelum, M., Hendriksen, L., van der Linden, P., Guda, K., Crommentuijn, K., Cornelissen-Wesseling, I., Diepstraten, J., Ellerbroek, J., Coenradie, S., Deben, D., Hurkens, K., Wong, D., Vromen, M., de Bock, M., Savelkoul, S., Wolters, S., Andrews, L., Jong, E., Kranenburg, R., Soares, J., Falcao, F., Solano, M., Viegas, E., Falcao, M., Farinha, H., Mendes, D., Rijo, J., Miarons, M., Gorgas, M. Q., Yubero, C. G., Portillo Horcajada, L., Keijzers, K., Lim, S., Ashfield, L., Bell, H., Fitzhugh, N., Fleming, G., Goodfellow, N., Hanley, J., Scott, M., Mooijaart, S. P., Gussekloo, J., Elders, P. & Peeters, G., 15 Dec 2024, In: Heliyon. 10, 23, e40456.
Research output: Contribution to journal › Article* › Academic › peer-review
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin
Abdullah-Koolmees, H., van den Nieuwendijk, J. F., Hoope, S. M. K. T., de Leeuw, D. C., Franken, L. G. W., Said, M. M., Seefat, M. R., Swart, E. L., Hendrikse, N. H. & Bartelink, I. H., Nov 2024, In: European journal of drug metabolism and pharmacokinetics. 49, 6, p. 689-699 11 p.
Research output: Contribution to journal › Article* › Academic › peer-review
All publications

Heshu Abdullah - Koolmees

Specialization

Focus of research

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study

Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19

Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin

Amsterdam UMC makes use of cookies